COHERUS BIOSCIENCES INC. - COMMON STOCK

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

16 Sep 2024 09:48:41 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

19 Aug 2024 14:06:12 By NetDania Notify

Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update

08 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

07 Aug 2024 14:09:32 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 Aug 2024 09:45:04 By NetDania Notify

Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024

01 Aug 2024 09:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

08 Jul 2024 09:58:08 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 Jul 2024 09:50:52 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

03 Jul 2024 09:46:52 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

02 Jul 2024 11:28:48 By NetDania Notify

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction

27 Jun 2024 08:26:59 By Nasdaq GlobeNewswire

Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

05 Jun 2024 09:00:00 By Nasdaq GlobeNewswire

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference

30 May 2024 09:00:00 By Nasdaq GlobeNewswire

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

23 May 2024 17:51:06 By Nasdaq GlobeNewswire

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA

23 May 2024 09:00:00 By Nasdaq GlobeNewswire

Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update

09 May 2024 16:01:00 By Nasdaq GlobeNewswire

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

09 May 2024 07:30:00 By Nasdaq GlobeNewswire

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer

08 May 2024 09:00:00 By Nasdaq GlobeNewswire

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

01 May 2024 16:30:00 By Nasdaq GlobeNewswire

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 Apr 2024 10:02:18 By Nasdaq GlobeNewswire